End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.84 NZD | +6.77% | -2.07% | -18.86% |
May. 01 | AFT Pharmaceuticals Signs Brazil Licensing Agreement for Maxigesic IV | MT |
Apr. 24 | New Zealand Shares Rise on US Earnings Rally; AFT Pharmaceuticals to Develop Topical Scar Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.86% | 182M | |
+32.36% | 694B | |
+29.85% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.66% | 239B | |
-3.39% | 209B | |
+10.25% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- AFT Stock
- News AFT Pharmaceuticals Limited
- Transcript : AFT Pharmaceuticals Limited, H1 2022 Earnings Call, Nov 18, 2021